A Randomized Clinical Trial of PF-05281104 Versus Herceptin® for Patients with HER2-Positive Breast Cancer (REFLECTIONS B327-04)
A Randomized, Double-Blind Pharmacokinetic Study Of PF-05280014 Plus Taxotere® And Carboplatin Versus
Herceptin® Plus Taxotere® And Carboplatin For The Neoadjuvant Treatment Of Patients With Operable HER2-Positive Breast Cancer
Category & Conditions: Cancer
Medicine: TRAZIMERA FOR INJECTION(TRASTUZUMAB-QYYP)
ClinicalTrials.gov Identifier (NCT): NCT02187744
Protocol ID: B3271004
PrintDownloadOpen Plain Language Summary Result: Click here